Naftopidil
Tier C — Watch / tradeNaftopidil
Targets：ADRA1
Brand：Avishot, Flivas, Eapidil
Indications (approved)：排尿困难, Benign prostatic hyperplasia
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
Frequently asked questions
What are the approved indications of Naftopidil?
Approved indications include: 排尿困难, Benign prostatic hyperplasia.
When does the Naftopidil patent expire?
No public expiry year is available for Naftopidil yet; this page updates once verified.
How many synthesis routes are recorded for Naftopidil?
1 synthesis routes are recorded; the shortest is 2 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Naftopidil intermediates?
All intermediates in Naftopidil routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Naftopidil intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29